Search

everythinglearnresearchcommunity

for

Search:↓

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Skin and mucosal issues can occur after COVID-19 in adults and children.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Higher androgen levels might make COVID-19 worse, especially in men.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may cause temporary hair loss in some people.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may harm male fertility and damage the reproductive system.